20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function
HD                     :Not dialysed. Dose as in normal renal function
HDF/high flux   :Not dialysed. Dose as in normal renal function
CAV/VVHD      :Not dialysed. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAlpha-blockers: avoid concomitant use with tolazoline Antidepressants: risk of hypertensive crisis with MAOIs and moclobemide Ciclosporin: may reduce risk of ciclosporin nephrotoxicityDopaminergics: effects possibly enhanced by entacapone; avoid concomitant use with rasagiline; risk of hypertensive crisis with selegiline
ADMINISTRATION
Reconstition
–
Route
IV peripherally into large vein (centrally for inotropic dose). Central route always preferable
Rate of Administration
Via CRIP as indicated below
Comments
Minimum dilution 200 mg in 50 mL Not compatible with sodium bicarbonate – rapid deactivation of dopamine
OTHER INFORMATION
Renal dose is 2–5 mcg/kg/min but little evidence that it can improve renal function Causes renal vasoconstriction at inotropic dose Cardiac and BP monitoring advised Very severe tissue damage caused by extravasation